[1] 吴文彬,陈昌枝.慢性阻塞性肺疾病并肺栓塞的危险因素及诊治研究现状[J].中国实用医药,2020,15(7):189-191. DOI:10.14163/j.cnki.11-5547/r.2020.07.083.
[2] 吴海燕,王宝玉. 低分子肝素对老年慢性阻塞性肺疾病急性加重期合并肺栓塞患者预后的影响[J]. 国际医药卫生导报,2018,24(10):1542-1545. DOI:10.3760/cma.j.issn.1007- 1245.2018.10.029.
[3] 王璟,秦文燕,赵馨. 慢性阻塞性肺疾病合并肺栓塞患者的临床特点分析[J]. 内科,2019,14(6):728-730. DOI:10.16121/j.cnki.cn45-1347/r.2019.06.31.
[4] 陈保安,黄慧,马景耀,等. 慢性阻塞性肺疾病合并肺栓塞的研究进展[J]. 海南医学,2019,30(16):2146-2150. DOI:10.3969/j.issn.1003-6350.2019.16.032.
[5] 孟令新,刘挨师. 慢性阻塞性肺疾病合并肺栓塞的临床及CT定量研究进展[J]. 医学综述,2018,24(3):596-600. DOI:10.3969/j.issn.1006-2084.2018.03.035.
[6] 王晓娟,方向阳. 慢性阻塞性肺疾病全球倡议2019:慢性阻塞性肺疾病诊断、治疗与预防全球策略解读[J]. 中国全科医学,2019,22(18):2141-2149. DOI:10.12114/j.issn.1007- 9572.2019.00.064.
[7] 李晶晶,郭磊,李聚财. CT肺动脉造影在肺血栓栓塞症诊断及危险评估中的应用[J]. 影像研究与医学应用,2019,3(7):100-101. DOI:10.3969/j.issn.2096-3807.2019.07.068.
[8] Kalemci S, Sarıhan A, Zeybek A, et al. Prevalence of pulmonary embolism in patients with obstructive sleep apnea and chronic obstructive pulmonary disease: the overlap syndrome[J].Heart Lung,2019,48(5):465. DOI:10.1016/j.hrtlng.2019.04.005.
[9] Park H, Cha SI, Lim JK,et al.Clinical relevance of chronic respiratory disease in Korean patients with pulmonary thromboembolism[J].J Thorac Dis,2019,11(6):2410-2419. DOI:10.21037/jtd.2019.05.53.
[10] 晋娜. 探讨检测凝血和纤溶功能对慢性阻塞性肺疾病患者病情和并发症的临床价值研究[J]. 中国医药指南,2018,16(3):13-14.
[11] Şahan E, Şahan S, Karamanlıoğlu M, et al.Prediction of new onset atrial fibrillation in patients with acute pulmonary embolism: the role of sPESI Score[J].Turk Kardiyol Dern Ars, 2019,47(3):191-197. DOI:10.5543/tkda.2018.78241.
[12] 杨芳,齐同珍,程育红,等. 华法林联合低分子肝素治疗慢性阻塞性肺疾病合并肺栓塞临床疗效及对血清cTnI的影响[J]. 解放军医药杂志,2019,31(4):78-81. DOI:10.3969/j.issn.2095-140X.2019.04.019.
[13] Jiménez D, Agustí A, Monreal M, et al. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease[J].Clin Cardiol,2019,42(3):346-351. DOI:10.1002/clc.23161.
[14] 吴文彬,陈昌枝,杨冬莲,等. D-二聚体、B型钠尿肽与血气在慢性阻塞性肺疾病继发肺栓塞的预测价值[J/CD]. 中华肺部疾病杂志(电子版),2019,12(6):743-746. DOI:10.3877/cma.j.issn.1674-6902.2019.06.015.
[15] 朱亚茜,马淑萍,董维刚,等. 血清白细胞介素38与慢性阻塞性肺疾病急性加重合并肺栓塞的相关性[J]. 中华医学杂志,2019,99(12):929-933. DOI:10.3760/cma.j.issn.0376- 2491.2019.12.010.
[16] Chen H, Liu D, Ge L, et al. Catestatin prevents endothelial inflammation and promotes thrombus resolution in acute pulmonary embolism in mice[J].Biosci Rep,2019,39(11):124-125. DOI:10.1042/BSR20192236.
[17] 吴继雄,张良金,张文俊,等. CT定量检测技术对COPD合并肺栓塞患者的诊断价值研究[J].齐齐哈尔医学院学报,2019,40(3):271-274.
[18] Weidman EK, Plodkowski AJ, Halpenny DF,等.双能量CT血管成像检测肺栓塞:碘图的附加益处[J].国际医学放射学杂志, 2019,42(1):109. DOI:10.19300/j.2019.r1119.
[19] 阿布都热苏力•吐尔孙,刘文亚,木合拜提•买合苏提,等.双源双能量CT肺栓塞指数和肺灌注缺损指数评价肺栓塞的相关研究[J].临床放射学杂志,2019,38(2):346-350. DOI:10.13437/j.cnki.jcr.2019.02.041.
[20] Yagi M, Taniguchi H, Kondoh Y, et al. CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis[J].Respirology,2017,22(10):1393- 1399.DOI: 10.1111/resp.13066.
|